Connect with us

Theranos Founder Charged With Massive Fraud by SEC

Published

on

Elizabeth Holmes, founder and chief executive of scandal-ridden blood-testing startup Theranos, Inc., has been formally charged with fraud by the U.S. Securities and Exchange Commission (SEC) alongside the company’s former president, Ramesh “Sunny” Balwani, for their role in fleecing investors of more than US$ 700 million using grossly exaggerated claims about the efficacy and business potential of their core product. Theranos and Holmes have agreed to settle the charges levied against them in court, with Holmes agreeing to pay US$ 500,000 in penalties, according to an announcement from the commission.

As part of the settlement, Holmes has forfeited her shares and voting control of Theranos and been barred from serving as an officer or director of a public company for the next 10 years. No such agreement was made with Balwani, who will face the SEC’s lawyers in federal district court in the Northern District Court of California. The charges come nearly two years after the SEC first began its investigation into Theranos, following an explosive report published by The Wall Street Journal in October 2015 quoting former employees that claimed the company’s revolutionary blood-testing equipment was built on a sham.

Big Dreams

A Stanford dropout whose penchant for black turtlenecks and promising technological marvels once drew comparisons to Silicon Valley deity Steve Jobs, Holmes captivated investors in 2003 with her pitch to develop a portable blood analyzer that could run a comprehensive suite of tests using only a few drops of blood, and at a fraction of the cost of devices currently on the market. In truth, however, Theranos’ mythical proprietary technology – dubbed the Edison machine after the prolific inventor – turned out to be capable of only a small fraction of what was promised, with the vast majority of tests being ran on traditional machines manufactured by companies like Siemens.

Attracting Big Names

[ Content protected for Sovereign Wealth Fund Institute Standard subscribers only. Please subscribe to view content. ]

SWFI First Read, June 21, 2018

Published

on

PSP Investments Nears Deal on Azelis

PSP Investments and EQT Partners (through fund EQT VIII) are in exclusive talks to acquire Belgium-based Azelis S.A. from funds managed by Apax Partners. Formed in 2001, Azelis is a specialty chemicals and food ingredients distributor. The transaction is subject to regulatory approvals.

Oxford Properties Wins Rights on Barangaroo Office Development

Melbourne-based Grocon Pty Ltd selected Oxford Properties, the real estate unit of OMERS, as a preferred partner for it’s a A$ 2 billion, 5.2-hectare Barangaroo Central project development. This is an office tower development. Oxford Properties essentially won the rights toward the project (rumored at a price of A$ 100 million), freeing the developer from a high-cost finance deal with Maxcap, a lender.

Investment Management Corporation of Ontario Selects Jean Michel as CIO

The Investment Management Corporation of Ontario named Jean Michel as chief investment officer. This role is effective July 3, 2018. Michel was executive vice president, advisory services to depositors and strategic analysis, at Caisse de Depot et Placement du Quebec (CDPQ).

Wil Warren Named President of Lexington Partners

[ Content protected for Sovereign Wealth Fund Institute Standard subscribers only. Please subscribe to view content. ]

Continue Reading

Large Public Asset Owners Commit to Goodman Brazil Logistics Partnership

Published

on

Canada Pension Plan Investment Board (CPPIB) unveiled plans to commit 500 million BRL (C$ 175 million) in equity for a 20% interest in the newly established Goodman Brazil Logistics Partnership to invest in prime logistics and industrial assets in the key gateway cities of São Paulo and Rio de Janeiro. [ Content protected for Sovereign Wealth Fund Institute Standard subscribers only. Please subscribe to view content. ]

Continue Reading

Mubadala Supports Two European Aquaculture Transactions

Published

on

Mubadala Investment Company is keen on growing exposure to agribusinesses whether in farming or aquaculture. With money from Mubadala and AMERRA Capital Management LLC, Andromeda Group acquired Nireus SA (at 74.34% stake) and Selonda SA at (79.62% stake), two European aquaculture companies that focus on sea bream and sea bass. [ Content protected for Sovereign Wealth Fund Institute Standard subscribers only. Please subscribe to view content. ]

Continue Reading

Popular

© 2008-2018 Sovereign Wealth Fund Institute. All Rights Reserved. Sovereign Wealth Fund Institute ® and SWFI® are registered trademarks of the Sovereign Wealth Fund Institute. Other third-party content, logos and trademarks are owned by their perspective entities and used for informational purposes only. No affiliation or endorsement, express or implied, is provided by their use. All material subject to strictly enforced copyright laws. Registration on or use of this site constitutes acceptance of our terms of use agreement which includes our privacy policy. Sovereign Wealth Fund Institute (SWFI) is a global organization designed to study sovereign wealth funds, pensions, endowments, superannuation funds, family offices, central banks and other long-term institutional investors in the areas of investing, asset allocation, risk, governance, economics, policy, trade and other relevant issues. SWFI facilitates sovereign fund, pension, endowment, superannuation fund and central bank events around the world. SWFI is a minority-owned organization.